D-0112-2024 Class III Terminated
FDA drug recall D-0112-2024 was initiated by Glenmark Pharmaceuticals Inc., USA on Oct 23, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study… The recall status is terminated (terminated Jul 5, 2024). Affected quantity: 8,448 30-count bottles, 168 1000-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 29, 2023
- Initiation Date
- Oct 23, 2023
- Termination Date
- Jul 5, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,448 30-count bottles, 168 1000-count bottles
Product description
Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b) 1000-count Bottle, NDC 68462-390-10: RX Only, Manufactured for: Glenmark, Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India,
Reason for recall
Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).
Distribution pattern
Nationwide in the USA
Code information
Lot # 17220002, Exp Date 11/30/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0112-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026